RAC 3.31% $1.61 race oncology ltd

ASH2023 - Sheba 2.0, page-101

  1. 917 Posts.
    lightbulb Created with Sketch. 228
    from Shebas perspective the trial wasn’t about FTO or cardio protection. That’s up to Race to investigate. The trial did allow for data collection on FTO so we should her more on that in time from Race once data is analysed but my understanding is it would still be anecdotal evidence. Although this should provide support for designing dedicated FTO trial.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.